JPMorgan Reinstates Insmed (INSM) at Overweight

May 20, 2026 4:30 AM

JPMorgan analyst Jessica Fye reinstates coverage on Insmed (NASDAQ: INSM) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found